Suven Life Sciences reports consolidated net loss of Rs 43.94 crore in the March 2025 quarter> |
Suven Life Sciences to declare Quarterly Results> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Disclosure under SEBI Takeover Regulations> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Disclosure under SEBI Takeover Regulations> |
Suven Life Sciences Ltd - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Trading Window> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Trading Window> |
Suven Life Sciences Ltd - Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Other General Purpose> |
Suven Life Sciences Ltd - Suven Life Sciences Limited - Monitoring Agency Report> |